Baveno VII Non-Invasive Criteria (cACLD / CSPH)
Applies the Baveno VII consensus non-invasive cut-offs to a reliable VCTE/FibroScan liver stiffness measurement and platelet count to classify compensated advanced chronic liver disease (cACLD) and clinically significant portal hypertension (CSPH), supporting non-selective beta-blocker decisions.